Get started
Author

Francesca Guidetti

Observed names: F. Guidetti, Guidetti, Francesca
ORCID: 0000-0001-7962-1501
Observed ORCID: 0000-0001-7962-1501
OpenAlex ID: A5023810403
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
2018 · Valeria Spina, Alessio Bruscaggin, et al. · Blood · 353
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
2017 · Chiara Tarantelli, Eugenio Gaudio, et al. · Clinical Cancer Research · 113
Genetic and phenotypic attributes of splenic marginal zone lymphoma
2021 · Ferdinando Bonfiglio, Alessio Bruscaggin, et al. · Blood · 100
Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease
2021 · Marianna Agudelo, Martin Palus, et al. · The Journal of Experimental Medicine · 68
PDF
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
2020 · Eugenio Gaudio, Chiara Tarantelli, et al. · Haematologica · 31
PDF
Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
2022 · Sara Napoli, Nicolas Munz, et al. · Cancers · 23
PDF
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
2023 · Francesca Guidetti, Alberto J. Arribas, et al. · Journal of Clinical Medicine · 18
PDF
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma
2021 · F. Bonfiglio, A. Bruscaggin, et al. · Hematological Oncology · 12
PDF
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas
2026 · Alberto J. Arribas, Eleonora Cannas, et al. · Blood · 11
Mechanisms of Adaptation to Ibrutinib in High Risk Chronic Lymphocytic Leukemia
2018 · Valeria Spina, Gabriela Forestieri, et al. · Blood · 10
An improved method to compute the solute and water derangements of hyperglycaemia
2007 · Ettore Bartoli, Luca Bergamasco, et al. · European Journal of Applied Physiology · 10
Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
2004 · Francesca Guidetti, Sandra Grazioli, et al. · PubMed · 10
Human herpesvirus type 8-associated primary lymphomatous effusion in an elderly HIV-negative patient: clinical and molecular characterization.
2002 · Daniela Buonaiuto, Davide Rossi, et al. · PubMed · 10
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
2021 · Sara Napoli, Luciano Cascione, et al. · Haematologica · 5
PDF
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses
2024 · Tomás Cervantes Rincón, Tania Kapoor, et al. · Cell Reports · 4
Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study
2018 · Francesca Guidetti, Alessio Bruscaggin, et al. · Blood · 3
Abstract C139: The IRAK4 inhibitor emavusertib (CA-4948) synergizes with second generation BTK inhibitors acalabrutinib and zanubrutinib in MYD88-L265P mutated lymphoma cell lines
2023 · Francesca Guidetti, Alberto J. Arribas, et al. · Molecular Cancer Therapeutics · 2
CDK9 pharmacological inhibition with PRT2527 has antitumor activity in marginal zone lymphoma models and can improve the effects of BTK, PI3K, and BCL2 inhibitors
2026 · Eleonora Cannas, Alberto J. Arribas, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Pharmacological inhibition of CXCR4 increases the anti-tumor activity of conventional and targeted therapies in B-cell lymphoma models
2025 · Laura Barnabei, Alberto J. Arribas, et al. · SSRN Electronic Journal · 1
429 | LOSS OF ENHANCER‐DERIVED lncRNA ZMIZ1‐AS1 INCREASES THE SENSITIVITY TO BCL2‐INHIBITOR VENETOCLAX IN MCL IN VITRO MODELS
2025 · F. Guidetti, N. Munz, et al. · Hematological Oncology · 1
PDF
Enhancer lncRNA LOC730338 modulates BCR signaling and immune evasion in lymphoma by regulating RNA homeostasis
2024 · Luciano Cascione, Francesca Guidetti, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Enhancer Rnas (ernas) Play a Role in the Response to Small Molecules and in the Development of Acquired Resistance in Marginal Zone Lymphoma (mzl)
2023 · S. Napoli, L. Cascione, et al. · Hematological Oncology · 1
PDF
HTGQC and shinyHTGQC: an R package and shinyR application for quality controls of HTG EDGE-seq protocols
2022 · Lodovico Terzi di Bergamo, Francesca Guidetti, et al. · Gigabyte · 1
PDF
Abstract P073: Pharmacological inhibition of IRAK4 with CA-4948 is beneficial in marginal zone lymphoma models with secondary resistance to PI3K and BTK inhibitors
2021 · Francesca Guidetti, Alberto J. Arribas, et al. · Molecular Cancer Therapeutics · 1
Ibrutinib modulates CD19 expression and improves efficacy of CD19-CAR T cells in B-cell lymphoma models
2026 · Sisi Wang, Alberto J Arribas, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Works count: 48
Citation count: 791
H-index: 10
I10-index: 13
Year
Topic
Type